Neurobehavioral Issues Increased in Children With Prenatal Fluoride Exposure
By Elana Gotkine HealthDay Reporter
TUESDAY, May 21, 2024 -- Prenatal fluoride exposure is associated with increased neurobehavioral problems, according to a study published online May 20 in JAMA Network Open.
Ashley J. Malin, Ph.D., from the University of Florida in Gainesville, and colleagues examined associations of third-trimester maternal urinary fluoride (MUF) with child neurobehavior at age 3 years in a prospective cohort study. Urine samples archived from 2017 to 2020 and neurobehavioral data assessed from 2020 to 2023 were obtained for a pregnancy cohort, consisting of predominantly Hispanic women residing in Los Angeles.
Data were included for 229 mother-child pairs who had specific gravity-adjusted MUF (MUFSG). The researchers found that a one-interquartile range increase in MUFSG was associated with significantly increased odds of the Total Problems T score being in the borderline clinical or clinical range (odds ratio, 1.83) and with a 2.29- and a 2.14-point increase in T score for the Internalizing Problems composite and the Total Problems composite, respectively.
"These findings suggest that there may be a need to establish recommendations for limiting exposure to fluoride from all sources during the prenatal period, a time when the developing brain is known to be especially vulnerable to injury from environmental insults," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults
WEDNESDAY, June 26, 2024 -- Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network...
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...
New Neurocognitive/Functional Morbidity Explored in SARS-CoV-2, MIS-C
WEDNESDAY, June 12, 2024 -- Children with acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome in children (MIS-C) with severe...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.